Tim Hirst, Australia

GPN Vaccines Ltd Research & Development

Author Of 2 Presentations

A NOVEL VACCINE THAT INDUCES SEROTYPE INDEPENDENT IMMUNITY TO STREPTOCOCCUS PNEUMONIAE (ID 383)

A NOVEL VACCINE (GAMMA-PN) THAT INDUCES SEROTYPE INDEPENDENT IMMUNITY TO STREPTOCOCCUS PNEUMONIAE (ID 203)